ProQR Therapeutics (PRQR) Shares Outstanding (2017 - 2025)

ProQR Therapeutics' Shares Outstanding history runs 9 years deep, the most recent figure standing at $122.6 million for Q4 2025.

• In Q4 2025, Shares Outstanding rose 9.09% year-over-year to $122.6 million; the TTM figure through Dec 2025 stood at $122.6 million (up 9.09% YoY), while the FY2025 annual figure was $122.6 million, up 9.09% from the prior year.
• Shares Outstanding came in at $122.6 million for Q4 2025 at ProQR Therapeutics, up from $112.4 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $122.6 million in Q4 2025 to a low of $81.6 million in Q4 2021.
• A 5-year average of $97.3 million and a median of $87.5 million in 2023 frame the typical range for Shares Outstanding.
• Across the five-year window, Shares Outstanding grew 1.1% in 2022 and grew 28.44% in 2024, its largest moves.
• ProQR Therapeutics' Shares Outstanding stood at $81.6 million in 2021, then advanced by 1.1% to $82.5 million in 2022, then climbed by 6.16% to $87.5 million in 2023, then gained by 28.44% to $112.4 million in 2024, then rose by 9.09% to $122.6 million in 2025.
• According to Business Quant data, Shares Outstanding over the past three periods registered $122.6 million, $112.4 million, and $87.5 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison